Sionna Therapeutics, Inc.: 1 tracked 2026 layoff event(s), 0 workers counted, highest AI score 4.
AI score 4 (80% interval 3–4) · evidence grade D · US · Pharma / Chemicals
Stated reason: On September 9, 2026, the Board of Directors (the “Board”) of Sionna Therapeutics, Inc. (the “Company”) approved a restructuring plan (the “Restructuring”) intended to focus its resources on advancing the Company’s SION-451 and SION-2222 dual combination program and extend the Company’s cash runway. The Restructuring includes a reduction of the Company’s workforce by approximately 46%, retaining core clinical, regula…
Why 4: Plant, store or site closure · Drivers: contrary evidence −0.6, industry AI exposure +0.5, role AI exposure +0.1
Signals: attribution 0.0, primary 0.0, exec 0.0, role exposure 0.608, industry exposure 0.712, AI investment 0.0, contrary 0.4 · named roles: Computer and Information Systems Managers, General and Operations Managers, Nursing Assistants, Registered Nurses
Headcount basis: not disclosed
Company AI financials (AI spending, revenue, earnings-call AI mentions) are coming soon to this page.
